This is the second article in a series exploring the Global Cannabis Market Expansion: Growth Trends and Considerations for the Future. See the first installment here.
In my first article, I covered a fairly broad overview of the cannabis market and various types of opportunities for those considering investing in this emerging industry. In this article, we’ll dig a bit deeper into the Canadian cannabis market, examining both the current state and growth forecasts, given their full adult-use market will go into effect on October 17th.
A Look Toward Canada
So what should we think about our friends to the North? As highlighted previously, Canada is the first G7 country to legalize cannabis, which will make it by far the biggest federally regulated market in the world. For comparison, Canada is a bit smaller than California population-wise, but given Canada’s free license to import/export and leverage capital markets, the nation has a strong advantage and market leading position. As such, there are no historical or industry comparisons that can be relied on. Canada will be forging new ground, making up the rules as they go … and the world will be watching.
Canada legalized medicinal cannabis in 2001 and the market has matured into a relative force in the ensuing years. Experts estimated that Canadians spent $4.63 billion on cannabis in 2017 alone, but 90% of that spend was “non-medical consumption,” in other words, black market sales.
Bullish prognosticators see ~$4B in existing market potential, with room for growth. But experienced industry investors know that uprooting entrenched black market operators is one of the largest questions facing a legal cannabis market. In the US, the black market has proven to be a difficult obstacle in every state that has legalized adult-use cannabis. In California, for example, black market operators – who don’t pay licensing fees or taxes or comply with regulations for safety and control – have been blamed for the slow development of the legal cannabis market. These “rogue operators” offer lower prices than their compliant competitors, and customers who have existing relationship with long-time dealers will often, ultimately, seek out the lowest prices. Canada’s large black market industry could slow growth as consumers may be reluctant to transition to a higher-priced legal market.
Legalization in Canada will help to both formalize controls around product quality and safety as well as provide economic stimulus from legal markets. There will also be a focused government and law enforcement initiative to convert black market operators into regulated businesses, or shut them down.
Ultimately, legalization on the Canadian scale is simply unprecedented and one of the few predictable factors is that there will be disruptions and difficulties as laws and regulations are rolled out and implemented. Growth in Canada’s cannabis industry is seemingly a likely outcome. The real question is how much, and how long will it take? And for the investment savvy, do current valuations of cannabis companies accurately capture this potential or currently overstate it?
Canadian Companies Riding the “Green Wave”
In recent years, Canada has become home to a growing number of public cannabis companies that are earning headlines with sky-high valuations, high-profile acquisitions and partnerships, and bold international growth strategies. But with these headlines may come a lot of empty hype, and it is essential to peek behind the glitz and glam to examine underlying operational and financial realities.
One reason Canadian cannabis companies have seen such growth is their unfettered access to capital markets. Since the cannabis markets are regulated at a federal level in Canada, companies compliant with Canadian law have been able to issue public offerings on major exchanges, including the Toronto Stock Exchange (TSX), TSX Venture Exchange (TSX-V), and the Canadian Securities Exchange (CSE).
The largest companies have used this access to capital to embark on ambitious operational expansions. For example: Canopy Growth has plans to add four million square feet of greenhouse space, has secured major distribution deals in numerous Canadian provinces, and is expanding globally with the launch of Latin American affiliate Canopy LATAM and the acquisition of Colombian based assets. Similarly, Aurora Cannabis has acquired another public cannabis company in MedReleaf, and has international ambitions of their own.
The deep field of public Canadian cannabis companies does not appear to be slowing momentum for companies seeking capital infusions, or for investors looking for the next big cannabis whale. Bucking the trend of listing on the Canadian exchanges, and forging new ground in the US, Tilray Inc.
Impressive growth plans have fueled astronomical valuations. Currently, the three largest cannabis companies are Aurora Cannabis
Numbers like those listed above have stoked fears of a “cannabis bubble,” threatening to burst with the first real bad news affecting the industry. And usually, such disparities in valuation and revenue or profit would send up red flags for investors. But for the cannabis industry, we truly just don’t know what these companies are worth now, or will be worth two, five or ten years down the line. We do know that growth prospects remain strong.
Why Was Growth Muted When Legalization Was Officially Announced?
Between November of 2017 and early January of 2018, the Global Cannabis Stock Index nearly tripled, largely fueled by anticipation of California’s massive adult-use market. The index has since dipped to 90 points, roughly half of its 180 point peak on January 3rd. Many expected a similar jump when Canada’s legalization was finally approved, but instead, growth has stalled and the index has dripped to its lowest level since December 2017.
A number of factors have contributed to the lack of investor enthusiasm around the announcement of Canadian legalization. Firstly, Canadian legalization was expected and has been hyped within the industry for over a year. When legalization was announced, the only real surprise was that it was to be implemented one to two months later than initially thought.
Secondly, in recent months the cannabis market has seen a number of significant offerings, including $52 million from Newstrike
Finally, the realities of the Canadian market seem to have taken hold. The rush of optimism that fueled the early 2018 spike has been replaced with concern about limited inventory, slowly growing demand, limited retail operations, and other regulatory factors.
Less Risk, Safer Rewards?
Investors nervous about talk of “bubbles” and over valuation have sought profit in companies related, but not wholly committed, to the cannabis industry. One such company that earned headlines at the end of 2017 is Constellation Brands
Constellation’s long-term plan is a hedge bet concerning how legal cannabis might affect the alcohol industry. They plan to sell cannabis-infused products themselves, and the additional exposure to the cannabis equity space has its own advantages. Investment in a diversified firm like Constellation are largely protected from the vagaries hounding the cannabis market, while should cannabis boom, Constellation and its investors will profit as well.
Similarly, lawn and garden care company Scotts Miracle-Gro
The variance in fortunes for the aforementioned companies establishing a stake in the cannabis industry are a microcosm of the severe variability that continues to confound investors.
In Conclusion
Canada will be the “canary in the coal mine” for cannabis legalization on an industrialized scale. Canadian companies in the cannabis space have been hard at work for many years developing cultivation and distribution operations in anticipation of legalization. With more and more pieces in place, the last and greatest variable will be consumer demand, in both the short and long-term. If demand fizzles, investors who heeded the red flags of aggressive valuations will be proved wise. Should demand explode (whether in six months or six years and domestically or internationally) today’s careful investors could be left out in the cold. As always, it comes down to risk appetite, investment portfolio theory and due diligence. Gaining a comprehensive understanding of both a company’s operations and leadership, and the regulatory framework they will be working within, is the only reliable information that differentiates safe investments from those likely to disappoint.
Evan Eneman
Evan Eneman, a serial entrepreneur, advisor, and investor, is the founder of three leading ventures steering the cannabis industry today. He is the CEO of ELLO, a professional services firm providing advisory, tax, and accounting services to the cannabis industry, the CEO of Fiorello, a branding and marketing agency offering a full suite of innovative business intelligence services, and is the founding partner of Casa Verde Capital, a venture capital firm focusing on ancillary opportunities in the cannabis industry.
Prior to his work in the cannabis industry, Eneman served as a director at PricewaterhouseCoopers, LLP for 12 years, advising clients on assurance, operations, strategy, cyber-security and privacy, working with marquee brands and leading Fortune 100 companies. Eneman was selected by the firm to serve as the representative for the SoCal market office for Project Belize, PwC’s innovative international development leadership program focused on financial literacy and environmental sustainability. Eneman’s early career was diverse with leadership roles in an array of categories including music, entertainment, and hospitality, where he developed and oversaw operations and production processes for boutique creative firms in New York and Los Angeles.
Eneman has served as an executive team member and the director of marketing and public relations at Minds Matter of Los Angeles, a program that helps to provide academically gifted, inner-city students from low-income families the opportunity to reach their full potential. Today, Eneman is the president of the Wharton Club of Southern California and co-founder and board member of the Wharton Alumni Angel Network and is an advisor to the Los Angeles Cannabis Task Force.
Trending Now
1
3
Read Next
Thought Leaders
Introducing the NEW Equities News: Transforming the world by investing in what matters most
Paula DeLaurentis
Mar 15, 2024
Economic
An opportunity for women in the clean-energy transition
Green Money
Mar 12, 2024
Economic
Making diversity in venture-capital funding a priority
Yinka Faleti
Mar 11, 2024
Environment
E-bike incentives are a costly way to cut carbon emissions, but they also promote health
The Conversation
Mar 7, 2024
3 dividend-paying health-care stocks that top analysts recommend
Benzinga
Mar 7, 2024
Economic
The true cost of food is far higher than what you spend at the grocery checkout
The Conversation
Mar 6, 2024
The Latest
Thought Leaders
Introducing the NEW Equities News: Transforming the world by investing in what matters most
Mar 15, 2024
Economic
An opportunity for women in the clean-energy transition
Mar 12, 2024
Economic
Making diversity in venture-capital funding a priority
Mar 11, 2024
Environment
E-bike incentives are a costly way to cut carbon emissions, but they also promote health
Mar 7, 2024